Colon and Rectal Cancer

Colon and rectal cancers, grouped together and often referred to as colorectal cancer, are the fourth most common cancers in the United States among both men and women. At Roswell Park, our colorectal cancer experts believe every patient is unique, and we approach cancer treatment on an individual and personal basis, treating the whole person, not just the cancer.

Our experts serve on boards of the National Comprehensive Cancer Network (NCCN) to create guidelines that specify the best ways of preventing, detecting, and treating specific types of cancer. The NCCN guidelines for colon cancer are the most widely used standards for cancer care.

Steven Nurkin, MD

Patients with suspected or newly-diagnosed colorectal cancer may have an initial evaluation within 24 hours. A team member will meet with you to outline further diagnostics, treatment or need for evaluation by the multidisciplinary team.

Our pathology department tests each patient’s colorectal cancer sample for the presence or absence of specific genetic mutations or unique characteristics. This information allows the colorectal team to determine whether a specific patient would benefit from a specific drug or therapy, sparing others from undergoing treatments unlikely to help them.

Our Endoscopy Center brings together Advanced Endoscopy and Interventional Pulmonology services into one facility where more than 90 percent of procedures are performed on an outpatient basis.

Pioneering Clinical Trials

Roswell Park strives to find better ways to treat this disease through clinical trials, many of which have been pioneered and launched by our own translational research team.